Sebastián Bernales
Direktor/Vorstandsmitglied bei METAGENOMI, INC.
Vermögen: 21 Mio $ am 30.04.2024
Profil
Sebastián Bernales is the founder of Keclon SA (2011) and Merken Biotech SpA (2016).
He is currently the Chief Executive Officer at Praxis Biotech LLC (since 2016) and a Director at Vedra Capital Management LLC, Metagenomi, Inc., Alesta Cleaning, Botanical Solutions, Phage Technologies SA, viTToria Biotherapeutics, Inc., Build Momentum, Inc., PhageLab Chile SpA, Humboldt Capital LLC, Droia Ventures, and Sake Holdings LLC.
He is also an Advisor at Miroculus, Inc. (since 2017) and a Board Member at Fundacion Ecoscience (since 2008).
Dr. Bernales previously worked as a Director-Research & Development at MediVation, Inc. (2015-2016) and as a Director at Metagenomi Technologies LLC.
He holds a doctorate degree from The University of California, San Francisco (2006) and an undergraduate degree from Pontificia Universidad Católica de Chile (2000).
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
METAGENOMI, INC.
8,48% | 01.04.2024 | 3 179 294 ( 8,48% ) | 21 Mio $ | 30.04.2024 |
Aktive Positionen von Sebastián Bernales
| Unternehmen | Position | Beginn |
|---|---|---|
| METAGENOMI, INC. | Direktor/Vorstandsmitglied | 01.12.2020 |
| Vedra Capital Management LLC | Direktor/Vorstandsmitglied | - |
Build Momentum, Inc.
 Build Momentum, Inc. Miscellaneous Commercial ServicesCommercial Services Build Momentum, Inc. was founded in 2005 and is a company that helps organizations design, develop, and deploy innovative cleantech projects. The company is based in Sacramento, CA and has subsidiaries in the United States. The company's vision is to create a world where clean energy, water, and transportation are abundant, affordable, and available to all. The company has a team of experts who can take on any aspect of a cleantech project, from developing a blueprint to commercialization. | Direktor/Vorstandsmitglied | - |
| Praxis Biotech LLC | Vorstandsvorsitzender | 01.07.2016 |
| Botanical Solutions | Direktor/Vorstandsmitglied | - |
| Droia Ventures | Corporate Officer/Principal | 01.08.2020 |
ViTToria Biotherapeutics, Inc.
 ViTToria Biotherapeutics, Inc. BiotechnologyHealth Technology viTToria Biotherapeutics, Inc. is a gene-edited cell therapeutics company based in Philadelphia, PA. The company is developing novel CAR-T cell therapies using their proprietary Senza5 platform, which maximizes stemness, durability, and target cell cytotoxicity. The technology is exclusively licensed from the University of Pennsylvania and has pipeline applications in oncology and autoimmune diseases. The company was founded by Bruce A. Peacock and Nicholas Siciliano, with Nicholas Siciliano serving as CEO since incorporation. | Direktor/Vorstandsmitglied | - |
| Fundacion Ecoscience | Direktor/Vorstandsmitglied | 01.11.2008 |
Ehemalige bekannte Positionen von Sebastián Bernales
| Unternehmen | Position | Ende |
|---|---|---|
MediVation, Inc. /MA/
 MediVation, Inc. /MA/ Internet Software/ServicesTechnology Services MediVation, Inc. /MA/ provides fully automated web-based communication systems to securely educate and communicate with patients online. The company is based in Needham, MA. MediVation, Inc. /MA was acquired by McKesson Corp. on July 05, 2000. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2016 |
| ░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░ | - |
| ░░░░░░ ░░ | ░░░░░░░░ | - |
| ░░░░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Sebastián Bernales
| The University of California, San Francisco | Doctorate Degree |
| Pontificia Universidad Católica de Chile | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| METAGENOMI, INC. | Health Technology |
| Private Unternehmen | 15 |
|---|---|
MediVation, Inc. /MA/
MediVation, Inc. /MA/ Internet Software/ServicesTechnology Services MediVation, Inc. /MA/ provides fully automated web-based communication systems to securely educate and communicate with patients online. The company is based in Needham, MA. MediVation, Inc. /MA was acquired by McKesson Corp. on July 05, 2000. | Technology Services |
Miroculus, Inc.
 Miroculus, Inc. Packaged SoftwareTechnology Services Miroculus, Inc. operates as a biotechnology company specializing in microRNA-based diagnostics. It offers a non-invasive microRNA detection platform for molecular data gathering, analysis, and interpretation applications. The company was founded by Alejandro Tocigl Domeyko, Jorge Soto and Fay Christodoulou and is headquartered in San Francisco, CA. | Technology Services |
| Vedra Capital Management LLC | |
Metagenomi Technologies LLC
 Metagenomi Technologies LLC BiotechnologyHealth Technology Metagenomi Technologies LLC engages in the development of curative therapeutics and gene-editing technologies and therapies. The company was founded by Brian C. Thomas in September 2016 and is headquartered in Emeryville, CA. | Health Technology |
Humboldt Capital LLC
 Humboldt Capital LLC Investment ManagersFinance Humboldt Capital LLC (Humboldt Capital) is a venture capital firm founded in 2020. The firm is headquartered in New York. | Finance |
| Alesta Cleaning | |
| Botanical Solutions | |
Phage Technologies SA
 Phage Technologies SA Miscellaneous Commercial ServicesCommercial Services Phage Technologies SA develops bacteriophage treatments for controlling bacteria in breeding processes in the poultry, livestock, and aquaculture industry. The company is based in Macul, Chile. The Chilean company aims to reduce the use of antibiotics for disease control. The CEO of the company is Hans Pieringer. | Commercial Services |
ViTToria Biotherapeutics, Inc.
ViTToria Biotherapeutics, Inc. BiotechnologyHealth Technology viTToria Biotherapeutics, Inc. is a gene-edited cell therapeutics company based in Philadelphia, PA. The company is developing novel CAR-T cell therapies using their proprietary Senza5 platform, which maximizes stemness, durability, and target cell cytotoxicity. The technology is exclusively licensed from the University of Pennsylvania and has pipeline applications in oncology and autoimmune diseases. The company was founded by Bruce A. Peacock and Nicholas Siciliano, with Nicholas Siciliano serving as CEO since incorporation. | Health Technology |
| Fundacion Ecoscience | |
| Merken Biotech SpA | |
| Droia Ventures | |
| Praxis Biotech LLC | |
Build Momentum, Inc.
Build Momentum, Inc. Miscellaneous Commercial ServicesCommercial Services Build Momentum, Inc. was founded in 2005 and is a company that helps organizations design, develop, and deploy innovative cleantech projects. The company is based in Sacramento, CA and has subsidiaries in the United States. The company's vision is to create a world where clean energy, water, and transportation are abundant, affordable, and available to all. The company has a team of experts who can take on any aspect of a cleantech project, from developing a blueprint to commercialization. | Commercial Services |
Keclon SA
 Keclon SA BiotechnologyHealth Technology Keclon SA engages in the development and generation of synthetic enzymes. Its technology platform allows to rapidly generating new and improved enzymes that can significantly reduce production costs using genetic engineering, synthetic biology and directed evolution tools. The company was founded by Hugo Menzella, Leandro Vetcher, Sebastian Bernales and Salvador Peiru, Rodolfo Cabrera in December 2011, and is headquartered in Rosario, Argentina. | Health Technology |
